CLColgate-Palmolive

Consumer Defensive

$88.27+10% 1Y

$88.27

$74.0652 weeks$98.53

Is the price fair?

Watch

A demanding price: at the top of its own P/E range and rich vs its sector.

2 to watch, 1 neutral

What the price assumes~+5% a year

Priced for ~5% a year FCF growth. Roughly in line with its three-year revenue growth of 4% a year.

Vs its own P/E rangedearer than 88% of its own historyderived

Expensive vs its own history: P/E 34.9 vs a 24.9 median over 41 quarters (+40% vs median).

Vs sector (EV/EBIT)24.9×

Sector median 16.6× across 78 covered peers. EV/EBIT counts debt as part of the price, so a cash-rich and a borrowed company can be compared on the same footing.

Unless marked, from derived, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)behind 75% of the market

FCF yieldmiddle of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What CL's price assumes

Colgate-Palmolive trades at 34.9× earnings against 23.6× for the median Household & Personal Products name, more expensive than its own group.

34.9

Trailing P/E · Household & Personal Products median 23.6 · 1.48× the median: the market pays up for this one

Price / sales: 3.40
Price / sales · today's price, trailing year to Jun 30, 2026
Free cash flow yield: 5.4%
Free cash flow yield · Household & Personal Products median 7.2%
Growth the price implies: +4.7%
Growth the price implies · The price pays for +4.7% free cash flow growth a year for a decade; the business has delivered +18% a year over the last three.

Details›

Price / booktoday's price, trailing year to Jun 30, 2026: 303
EV / EBITtoday's price, trailing year to Jun 30, 2026: 24.9
EV / salestoday's price, trailing year to Jun 30, 2026: 3.71
Consumer Defensive median P/E142 names: 20.2
Household & Personal Products median P/E18 names: 23.6
Free cash flow, trailing twelve months: $3.86B
Market capitalisation: $71.6B
3-year revenue growth: +4.1%
3-year free cash flow growth: +18%

What the market has paid for these earnings: 41 quarters of its own multiple × $2.53 of trailing earnings per share
Method	Per share
Its own P/E history, lower quartile	$55.59
Its own P/E history, median	$63.02
Its own P/E history, upper quartile	$75.09
52-week range	$74.06 – $98.53
Today	$88.27

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

On our screens:Quality at a reasonable price Stocks that buy back more than they dilute

Household & Personal Products

The closest names by size in the same industry